Capitol Health 将来の成長

Future 基準チェック /46

Capitol Health利益と収益がそれぞれ年間68.4%と6.4%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に15.1% 68.5%なると予測されています。

主要情報

68.4%

収益成長率

68.5%

EPS成長率

Healthcare 収益成長	25.2%
収益成長率	6.4%
将来の株主資本利益率	15.1%
アナリストカバレッジ	Good
最終更新日	17 Oct 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

CHIA:CAJ - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2027	284	19	21	50	7
6/30/2026	270	15	19	45	8
6/30/2025	252	13	15	39	8
6/30/2024	235	-15	17	36	N/A
3/31/2024	232	-5	14	36	N/A
12/31/2023	229	6	12	36	N/A
9/30/2023	219	-3	16	37	N/A
6/30/2023	210	-12	21	37	N/A
3/31/2023	198	-12	18	33	N/A
12/31/2022	187	-12	16	28	N/A
9/30/2022	186	-1	18	30	N/A
6/30/2022	184	11	19	32	N/A
3/31/2022	186	12	22	34	N/A
12/31/2021	188	14	26	36	N/A
9/30/2021	183	13	29	39	N/A
6/30/2021	178	12	33	41	N/A
3/31/2021	168	8	33	43	N/A
12/31/2020	159	4	34	45	N/A
9/30/2020	156	3	28	40	N/A
6/30/2020	154	1	23	35	N/A
3/31/2020	156	8	18	30	N/A
12/31/2019	157	15	12	25	N/A
9/30/2019	153	20	8	22	N/A
6/30/2019	149	24	4	18	N/A
12/31/2018	137	-2	5	15	N/A
9/30/2018	128	-6	4	13	N/A
6/30/2018	119	-11	4	11	N/A
12/31/2017	110	2	N/A	15	N/A
9/30/2017	108	2	N/A	15	N/A
6/30/2017	107	2	N/A	15	N/A
12/31/2016	80	1	N/A	13	N/A
9/30/2016	92	2	N/A	13	N/A
6/30/2016	104	2	N/A	13	N/A
3/31/2016	148	-2	N/A	15	N/A
12/31/2015	139	1	N/A	13	N/A
9/30/2015	125	3	N/A	14	N/A
6/30/2015	110	4	N/A	16	N/A
3/31/2015	103	6	N/A	16	N/A
12/31/2014	95	9	N/A	16	N/A
9/30/2014	92	8	N/A	14	N/A
6/30/2014	90	7	N/A	12	N/A
3/31/2014	83	6	N/A	10	N/A
12/31/2013	77	5	N/A	7	N/A

アナリストによる今後の成長予測

収入対貯蓄率: CAJは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.6% ) よりも高い成長率であると考えられます。

収益対市場: CAJ今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: CAJ今後 3 年以内に収益を上げることが予想されます。

収益対市場: CAJの収益 ( 6.4% ) Australian市場 ( 5.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: CAJの収益 ( 6.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: CAJの自己資本利益率は、3年後には低くなると予測されています ( 15.1 %)。

Capitol Health 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Recent updates

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Capitol Health Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Now 21% undervalued after recent price drop

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 25% undervalued after recent price drop

Now 20% undervalued after recent price drop

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings released: AU$0.011 loss per share (vs AU$0.01 profit in FY 2022)

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.008 profit in 1H 2022)

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings released: EPS: AU$0.01 (vs AU$0.012 in FY 2021)

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

New 90-day high: AU$0.30

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

New 90-day high: AU$0.27

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Capitol Health Limited Announces Resignation of Marcell Judkins as Chief Financial Officer

New 90-day high: AU$0.27

Capitol Health Limited (ASX:CAJ) completed the acquisition of 90% stake in Fowler Simmons Radiology.

Capitol Health Limited to Report Fiscal Year 2020 Results on Aug 26, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘